Steel Partners Holdings L.P.
SPLP-PA News Today: Stay Updated with the Latest Steel Partners Holdings L.P. News in Real Time
Find SPLP-PA news now at Meyka AI. Stay informed with the latest Steel Partners Holdings L.P. stocks updates, including price news, market analysis, and expert insights.
Oji Holdings Stock Jumps 2.5% on Earnings Beat, Dividend Boost
3861.T stock rises 2.5% after earnings announcement. Oji Holdings boosts dividend 26%, trades at ¥857 on JPX.
Micro-Mechanics (Holdings) Ltd. Stock Surges 138% YTD on Semiconductor Demand
5DD.SI stock climbs 138% year-to-date as semiconductor precision parts demand accelerates. Meyka AI rates the stock with a B grade.
Twintek Investment Holdings Limited (6182.HK) Holds Steady at HK$0.74 Amid Sector Recovery
6182.HK stock trades flat at HK$0.74 on HKSE. Building materials and construction services firm shows resilience with 150% six-month gain.
SCND Stock: CFO Rovinsky Acquires Options May 15, 2026
Scientific Industries CFO Zachary Rovinsky acquires 20,000 stock options at $0.80 per share. Initial ownership filing reveals $16,000 transaction.
NVGS Navigator Holdings CFO Chapman Gary Insider Filing May 15, 2026
Navigator Holdings CFO Chapman Gary files initial ownership of 46,308 employee share options worth $830,765. NVGS insider trading update.
INDV Insider Trading: Barry Patrick Restricted Stock Units Filing May 15, 2026
Barry Patrick A, Chief Commercial Officer at Indivior Pharmaceuticals, filed initial ownership of 130,312 restricted stock units on January 7, 2026.
Man Wah Holdings Stock Drops 7.5% as Furniture Demand Weakens
Man Wah Holdings (1999.HK) falls 7.5% to HK$3.97 on earnings concerns. Furniture maker faces revenue headwinds amid consumer spending slowdown.
PLNH Stock: McLean Stephen Insider Filing May 15, 2026
Planet 13 Holdings insider Stephen McLean files Form 3 with 450,847 restricted stock units. Interim CFO ownership disclosure on May 15, 2026.
XtalPi Holdings Ltd Slips 7.5% as AI Drug Discovery Faces Valuation Pressure
XtalPi Holdings (2228.HK) drops 7.5% to HK$8.18 on valuation concerns. AI drug discovery firm trades below 50-day average amid sector headwinds.